Elevance Health Inc.
ELV NYSEHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Jul 15, 2026
ET
EPS Est.
6.21
EPS Actual
7.45
Revenue Est.
$48.88B
Revenue Actual
$49.83B
Next Earnings Report Date unconfirmed
Date
Oct 21, 2026 · Wed
Time
Time TBD
Fiscal Period
--
EPS Est.
4.70
Revenue Est.
$49.3B
Company Overview
Elevance Health Inc. (ticker ELV) is listed on NYSE with a market cap of about $86.86B. Its next earnings report is expected on Oct 21, 2026 (ET), Time TBD (date pending company confirmation), with consensus EPS of 4.70. In the last 15 reported quarters, EPS beat consensus estimates 13 times.
Actual EPS TrendRecently15Term · Jan 25, 2023 → Jul 15, 2026
Jan 25, 2023Range: 3.33 ~ 12.58Jul 15, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 15, 2026 | -- | 6.21 | Above forecast↑7.45 | $48.88B | $49.83B |
| Apr 22, 2026 | -- | 10.82 | Above forecast↑12.58 | $48.2B | $49.49B |
| Jan 28, 2026 | -- | 3.10 | 3.33 | $49.84B | $49.31B |
| Oct 21, 2025 | -- | 4.93 | Above forecast↑6.03 | $49.38B | $50.09B |
| Jul 17, 2025 | -- | 8.91 | 8.84 | $48.19B | $49.42B |
| Apr 22, 2025 | -- | 11.41 | 11.97 | $46.3B | $48.77B |
| Jan 23, 2025 | -- | 3.80 | 3.84 | $44.95B | $45.44B |
| Oct 17, 2024 | -- | 9.66 | 8.37 | $43.47B | $45.15B |
| Jul 17, 2024 | -- | 10.01 | 10.12 | $42.99B | $43.65B |
| Apr 18, 2024 | -- | 10.53 | 10.64 | $42.49B | $42.58B |
| Jan 24, 2024 | -- | 5.55 | 5.62 | $42.09B | $42.65B |
| Oct 18, 2023 | -- | 8.45 | 8.99 | $41.97B | $42.85B |
| Jul 19, 2023 | -- | 8.80 | 9.04 | $41.5B | $43.67B |
| Apr 19, 2023 | -- | 9.26 | 9.46 | $40.83B | $42.17B |
| Jan 25, 2023 | -- | 5.20 | 5.23 | $39.77B | $39.93B |
Original Filings (SEC)
10-Q2026-07-15 ↗
8-K2026-07-15 ↗
8-K2026-06-10 ↗
8-K2026-05-13 ↗
10-Q2026-04-22 ↗
8-K2026-04-22 ↗
8-K2026-03-10 ↗
8-K2026-03-02 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
